U.S. Food and Drug Administration (FDA) · United States

FDA Antidandruff Monograph Compliance

Limits dandruff, seborrheic dermatitis and psoriasis claims to those the OTC monograph permits for the product's active ingredient, and bars cure or permanence claims.

21 U.S.C. 355h(a)(1); OTC Monograph M032 (former 21 CFR 358 Subpart H)

What is FDA Antidandruff Monograph Compliance?

Limits dandruff, seborrheic dermatitis and psoriasis claims to those the OTC monograph permits for the product's active ingredient, and bars cure or permanence claims. Apply to U.S. labels, listings and ads for medicated shampoos and scalp treatments. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability and any

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

customers, general_audience, general_adults_18plus · OTC Drug, Cosmetics · cpg

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Limits dandruff, seborrheic dermatitis and psoriasis claims to those the OTC monograph permits for the product's active ingredient, and bars cure or permanence claims.

How can marketing teams comply?

Apply to U.S. labels, listings and ads for medicated shampoos and scalp treatments.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 355h(a)(1); OTC Monograph M032 (former 21 CFR 358 Subpart H)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
OTC Drug, Cosmetics
Audiences
customers, general_audience, general_adults_18plus

Frequently asked questions

What is FDA Antidandruff Monograph Compliance?

Limits dandruff, seborrheic dermatitis and psoriasis claims to those the OTC monograph permits for the product's active ingredient, and bars cure or permanence claims.

Who does this rule apply to?

customers, general_audience, general_adults_18plus · OTC Drug, Cosmetics · cpg

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan